Literature DB >> 9355968

Expression of hyaluronan in benign and malignant breast lesions.

P K Auvinen1, J J Parkkinen, R T Johansson, U M Agren, R H Tammi, M J Eskelinen, V M Kosma.   

Abstract

Hyaluronan (HA) is one of the extracellular-matrix components involved in wound healing, tumour growth and metastasis. Due to the limited data on HA expression in benign and malignant breast lesions, we analyzed its presence in these lesions by using the biotinylated-hyaluronan-binding region and the link-protein complex (bHABC) of cartilage proteoglycan as a specific probe. In all benign breast lesions, the expression of HA was restricted to the stromal connective tissue, the ductal epithelial cells being completely devoid of HA. In malignant breast tumours, the intensity of stromal HA staining was significantly stronger than in benign lesions. In addition, HA was detected on cell membranes or in cytoplasms of adenocarcinoma cells, in some cases of ductal carcinoma in situ and in 31% of malignant tumours. The staining pattern was mostly similar in all breast-cancer types studied, i.e., ductal, lobular, tubular, mucinous and medullary. In ductal breast cancer, intense HA expression in stroma and carcinoma cells correlated statistically significantly to poor differentiation of carcinoma, suggesting that altered HA expression may affect the mechanisms of breast-cancer progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9355968     DOI: 10.1002/(sici)1097-0215(19971021)74:5<477::aid-ijc1>3.0.co;2-0

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites.

Authors:  R M Peterson; Q Yu; I Stamenkovic; B P Toole
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

2.  Secretory products of breast cancer cells upregulate hyaluronan production in a human osteoblast cell line.

Authors:  Nandita Bose; Anna M Masellis
Journal:  Clin Exp Metastasis       Date:  2006-04-27       Impact factor: 5.150

3.  Tumor Microenvironment Remodeling by 4-Methylumbelliferone Boosts the Antitumor Effect of Combined Immunotherapy in Murine Colorectal Carcinoma.

Authors:  Mariana Malvicini; Esteban Fiore; Valentina Ghiaccio; Flavia Piccioni; Miguel Rizzo; Lucila Olmedo Bonadeo; Mariana García; Marcelo Rodríguez; Juan Bayo; Estanislao Peixoto; Catalina Atorrasagasti; Laura Alaniz; Jorge Aquino; Pablo Matar; Guillermo Mazzolini
Journal:  Mol Ther       Date:  2015-06-24       Impact factor: 11.454

4.  Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma.

Authors:  Sophia Adamia; Tony Reiman; Mary Crainie; Michael J Mant; Andrew R Belch; Linda M Pilarski
Journal:  Blood       Date:  2005-02-24       Impact factor: 22.113

5.  Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.

Authors:  P Auvinen; R Tammi; J Parkkinen; M Tammi; U Agren; R Johansson; P Hirvikoski; M Eskelinen; V M Kosma
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

6.  Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer.

Authors:  Anirban Ghosh; Hemalatha Kuppusamy; Linda M Pilarski
Journal:  J Biol Chem       Date:  2009-05-18       Impact factor: 5.157

7.  Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells.

Authors:  Kozo Hosono; Yoshihiro Nishida; Warren Knudson; Cheryl B Knudson; Takahiro Naruse; Yoshitaka Suzuki; Naoki Ishiguro
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

8.  Modulation of TGFbeta1-dependent myofibroblast differentiation by hyaluronan.

Authors:  Jason Webber; Robert H Jenkins; Soma Meran; Aled Phillips; Robert Steadman
Journal:  Am J Pathol       Date:  2009-06-18       Impact factor: 4.307

9.  Synthesis of hyaluronan in oesophageal cancer cells is uncoupled from the prostaglandin-cAMP pathway.

Authors:  S Twarock; K Röck; M Sarbia; A A Weber; R U Jänicke; J W Fischer
Journal:  Br J Pharmacol       Date:  2009-03-26       Impact factor: 8.739

10.  Hyaluronan orchestrates transforming growth factor-beta1-dependent maintenance of myofibroblast phenotype.

Authors:  Jason Webber; Soma Meran; Robert Steadman; Aled Phillips
Journal:  J Biol Chem       Date:  2009-02-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.